Skip to main content
. Author manuscript; available in PMC: 2012 Nov 25.
Published in final edited form as: J Thorac Oncol. 2010 Jun;5(6):810–817. doi: 10.1097/jto.0b013e3181d89f95

Table 1.

Baseline patients’ characteristics and initial clinical diagnosis*

Characteristics Placebo (N=126) Chemo (N=124) p-value
Age – median (min, max) 63(40,81) 61(37,78) 0.2180
Gender Male 84 (67%) 77 (62%) 0.4505
Female 42 (33%) 47 (38%)
Race White 109 (87%) 112 (91%) 0.3296
Non-white 16 (13%) 11 (9%)
Performance Status Fully active 71 (57%) 68 (55%) 0.7011
Others 53 (43%) 56 (45%)
Weight loss in previous 6 months < 5% 96 (81%) 92 (80%) 0.7932
≥ 5% 22 (19%) 23 (20%)
Symptoms Presence 96 (76%) 99 (80%) 0.4863
Absence 30 (24%) 25 (20%)
Diagnosis Squamous cell 40 (32%) 46 (37%) 0.6440
Adenocarcinoma 68 (54%) 61 (50%)
Other types 18 (14%) 16 (13%)
Smoking History Yes 125 (99%) 120 (97%) 0.1696
No 1 (1%) 4 (3%)
*

The p-value for age was from the t-test, while Chi-square tests were used for the categorical variables.